New York, NY - (ACCESSWIRE) - 10/09/2013 - Equity Profile Report initiates its NASDAQ Active Stock Weekly Watch List adding Tesla Motors, Inc. (NASDAQ:TSLA), Himax Technologies, Inc. (NASDAQ:HIMX), Agenus Inc. (NASDAQ:AGEN) and Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Tesla Motors, Inc. (NASDAQ:TSLA) a company that designs, develops, manufactures, and sells electric vehicles and electric vehicle powertrain components closed down in its previous session (-4.56%) on 13,753,513 shares traded as Tesla's Model S overtakes VW Golf as Norway's best-selling car. Tesla Motors, Inc. (NASDAQ:TSLA) is currently down (-10.95%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Tesla Motors, Inc. (NASDAQ:TSLA)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=TSLA&SubId=AW
Himax Technologies, Inc. (NASDAQ:HIMX) a company that designs, develops, and markets semiconductors for flat panel displays closed down in its previous session (-5.00%) on 9,622,772 shares traded. Himax Technologies, Inc. (NASDAQ:HIMX) is currently down (-14.27%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Himax Technologies, Inc. (NASDAQ:HIMX)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=HIMX&SubId=AW
Agenus Inc. (NASDAQ:AGEN) a biotechnology company that engages in developing and commercializing technologies to treat cancers and infectious diseases closed up in its previous session (+8.63%) on 9,335,085 shares traded after AGENUS INC Filed SEC form 8-K, Other Events, Financial Statements and Exhibits. Agenus Inc. (NASDAQ:AGEN) is currently up (+42.45%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Agenus Inc. (NASDAQ:AGEN)
Clic Here: http://www.equityprofilereport.com/Survey.aspx?stock=AGEN&SubId=AW
Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States closed down in its previous session (-9.05%) on 5,929,420 shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently down (-26.31%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=CLDX&SubId=AW
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.equityprofilereport.com/
Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Contact Info:Equity Profile Report
[email protected]